25019963|t|8-Hydroxyquinoline Schiff-base compounds as antioxidants and modulators of copper-mediated Abeta peptide aggregation.
25019963|a|One of the hallmarks of Alzheimer's disease (AD) in the brain are amyloid-beta (Abeta) plaques, and metal ions such as copper(II) and zinc(II) have been shown to play a role in the aggregation and toxicity of the Abeta peptide, the major constituent of these extracellular aggregates. Metal binding agents can promote the disaggregation of Abeta plaques, and have shown promise as AD therapeutics. Herein, we describe the syntheses and characterization of an acetohydrazone (8-H2QH), a thiosemicarbazone (8-H2QT), and a semicarbazone (8-H2QS) derived from 8-hydroxyquinoline. The three compounds are shown to be neutral at pH7.4, and are potent antioxidants as measured by a Trolox Equivalent Antioxidant Capacity (TEAC) assay. The ligands form complexes with Cu(II), 8-H2QT in a 1:1 metal:ligand ratio, and 8-H2QH and 8-H2QS in a 1:2 metal:ligand ratio. A preliminary aggregation inhibition assay using the Abeta1-40 peptide showed that 8-H2QS and 8-H2QH inhibit peptide aggregation in the presence of Cu(II). Native gel electrophoresis/Western blot and TEM images were obtained to give a more detailed picture of the extent and pathways of Abeta aggregation using the more neurotoxic Abeta1-42 in the presence and absence of Cu(II), 8-H2QH, 8-H2QS and the drug candidate PBT2. An increase in the formation of oligomeric species is evident in the presence of Cu(II). However, in the presence of ligands and Cu(II), the results match those for the peptide alone, suggesting that the ligands function by sequestering Cu(II) and limiting oligomer formation in this assay. 
25019963	0	18	8-Hydroxyquinoline	Chemical	MESH:D015125
25019963	19	30	Schiff-base	Chemical	MESH:D012545
25019963	75	81	copper	Chemical	MESH:D003300
25019963	91	96	Abeta	Gene	351
25019963	142	161	Alzheimer's disease	Disease	MESH:D000544
25019963	163	165	AD	Disease	MESH:D000544
25019963	184	196	amyloid-beta	Gene	351
25019963	198	203	Abeta	Gene	351
25019963	218	223	metal	Chemical	MESH:D008670
25019963	237	247	copper(II)	Chemical	-
25019963	252	260	zinc(II)	Chemical	MESH:D015032
25019963	315	323	toxicity	Disease	MESH:D064420
25019963	331	336	Abeta	Gene	351
25019963	403	408	Metal	Chemical	MESH:D008670
25019963	458	463	Abeta	Gene	351
25019963	499	501	AD	Disease	MESH:D000544
25019963	577	591	acetohydrazone	Chemical	-
25019963	593	599	8-H2QH	Chemical	-
25019963	604	621	thiosemicarbazone	Chemical	MESH:D013882
25019963	623	629	8-H2QT	Chemical	-
25019963	638	651	semicarbazone	Chemical	MESH:D012664
25019963	653	659	8-H2QS	Chemical	-
25019963	674	692	8-hydroxyquinoline	Chemical	MESH:D015125
25019963	793	799	Trolox	Chemical	MESH:C010643
25019963	878	884	Cu(II)	Chemical	-
25019963	886	892	8-H2QT	Chemical	-
25019963	902	907	metal	Chemical	MESH:D008670
25019963	926	932	8-H2QH	Chemical	-
25019963	937	943	8-H2QS	Chemical	-
25019963	953	958	metal	Chemical	MESH:D008670
25019963	1056	1062	8-H2QS	Chemical	-
25019963	1067	1073	8-H2QH	Chemical	-
25019963	1121	1127	Cu(II)	Chemical	-
25019963	1260	1265	Abeta	Gene	351
25019963	1293	1303	neurotoxic	Disease	MESH:D020258
25019963	1345	1351	Cu(II)	Chemical	-
25019963	1353	1359	8-H2QH	Chemical	-
25019963	1361	1367	8-H2QS	Chemical	-
25019963	1391	1395	PBT2	Chemical	-
25019963	1478	1484	Cu(II)	Chemical	-
25019963	1526	1532	Cu(II)	Chemical	-
25019963	1634	1640	Cu(II)	Chemical	-
25019963	Association	MESH:D008670	MESH:D000544
25019963	Association	MESH:D003300	MESH:D012545
25019963	Association	MESH:D015032	351
25019963	Association	MESH:D000544	351
25019963	Association	MESH:D015032	MESH:D064420
25019963	Association	MESH:D015125	351
25019963	Association	MESH:D003300	MESH:D015125
25019963	Positive_Correlation	MESH:D020258	351
25019963	Association	MESH:D008670	351
25019963	Association	MESH:D008670	MESH:D064420
25019963	Association	MESH:D003300	351
25019963	Association	MESH:D012545	351

